Teva plans to raise Mylan bid by as much as $2 billion: Bloomberg

(Reuters) – Teva Pharmaceutical Industries Ltd is preparing to raise its bid for rival drugmaker Mylan NV by as much as $2 billion, to $43 billion, Bloomberg reported on Monday, citing people familiar with the matter.